EC-Paclitaxel und Paclitaxel-EC in der primären Therapie des Mammakarzinoms

Autor: C Spohn, V Petersen, H Eschenburg, T Göhler, G Innig, A Schlichting, M Konias, HJ Hurtz, DT Baerens, C Priebe-Richter, HW Tessen

Publikováno v: Senologie - Zeitschrift für Mammadiagnostik und -therapie. 14:A1-A53

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d9496c6995f2cea1f259c06863bf3741
https://doi.org/10.1055/s-0037-1602495

[Erlotinib plus Gemcitabine in metastatic pancreatic cancer: Results from a non-interventional trial].

Autor: Westphalen CB; Medizinische Klinik und Poliklinik III, Klinikum der Universität München - Campus Großhadern, München, Germany., Heinemann V; Medizinische Klinik und Poliklinik III, Klinikum der Universität München - Campus Großhadern, München, Germany., Tessen HW; Onkologische Kooperation Harz, Goslar, Germany., Groschek M; Hämatologie - Onkologie Stolberg, Stolberg, Germany., Hoeffkes HG; Klinikum Fulda, Medizinische Onkologie und Hämatologie, Fulda, Germany., Marschner N; Onkologische Schwerpunktpraxis, Freiburg, Germany., Schulze M; Ambulante Onkologie Ostsachsen, Zittau, Germany., Beringer A; F Hoffmann-La Roche AG, Basel, Switzerland., Waldschmidt D; Department of Gastroenterology and Hepatology, University Hospital of Cologne, Germany.

Publikováno v: Zeitschrift fur Gastroenterologie [Z Gastroenterol] 2020 Apr; Vol. 58 (4), pp. 332-340. Date of Electronic Publication: 2020 Feb 12.

Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study).

Autor: Wehmeyer J; Hämatologisch-onkologische Gemeinschaftspraxis, Münster, Germany., Zaiss M; Praxis für interdisziplinäre Onkologie & Hämatologie, Freiburg, Germany., Losem C; Praxis für Onkologie und Hämatologie, Neuss, Germany., Schmitz S; Gemeinschaftspraxis für Hämatologie und Onkologie, Köln, Germany., Niemeier B; iOMEDICO Clinical Research Organization, Freiburg, Germany., Harde J; iOMEDICO Clinical Research Organization, Freiburg, Germany., Hannig CV; Gemeinschaftspraxis Dres. Pott/ Tirier/ Hannig, Bottrop, Germany., Harich HD; Onkologische Schwerpunktpraxis Hof, Hof, Germany., Müller J; iOMEDICO Clinical Research Organization, Freiburg, Germany., Klausmann M; Studienzentrum Aschaffenburg, Aschaffenburg, Germany., Tessen HW; Studienzentrum MVZ Onkologische Kooperation Harz, Goslar, Germany., Potthoff K; Praxis für interdisziplinäre Onkologie & Hämatologie, Freiburg, Germany.

Publikováno v: European journal of haematology [Eur J Haematol] 2018 Dec; Vol. 101 (6), pp. 766-773. Date of Electronic Publication: 2018 Oct 25.

Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study.

Autor: von Verschuer U; Ambulatory Health Care Centre for Haematology and Oncology, Henricistr. 40, 45136, Essen, Germany. Electronic address: praxis@onkologie-essen.de., Schnell R; Outpatient Centre for Internistic Haematology and Oncology, Kölner Str. 9, 50226, Frechen, Germany. Electronic address: rschnell@pioh.de., Tessen HW; Ambulatory Health Care Centre for Oncology, Kösliner Str. 14, 38642, Goslar, Germany. Electronic address: dr.tessen@onkologie-goslar.de., Eggert J; Oncology Outpatient Centre, Xantener Str. 40, 47441, Moers, Germany. Electronic address: eggert@onkologie-moers.de., Binninger A; Clinical Epidemiology and Health Economics, iOMEDICO, Hanferstr. 28, 79108, Freiburg, Germany. Electronic address: adrian.binninger@iomedico.com., Spring L; Clinical Epidemiology and Health Economics, iOMEDICO, Hanferstr. 28, 79108, Freiburg, Germany. Electronic address: lisa.spring@iomedico.com., Jänicke M; Clinical Epidemiology and Health Economics, iOMEDICO, Hanferstr. 28, 79108, Freiburg, Germany. Electronic address: martina.jaenicke@iomedico.com., Marschner N; Outpatient Centre for Interdisciplinary Oncology and Haematology, Wirthstrasse 11c, 79110, Freiburg, Germany. Electronic address: norbert.marschner@onkologie-freiburg.de.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2017 Oct; Vol. 112, pp. 216-224. Date of Electronic Publication: 2017 Sep 12.

A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO).

Autor: Sehouli J; Gynecology and Gynecologic Oncology, Charité University Medicine Campus Virchow, Augustenburger Platz 1, 13353, Berlin, Germany. jalid.sehouli@charite.de., Tomè O; Gynecologic Cancer Centre Karlsruhe, St. Vincentius Clinics, Karlsruhe, Germany., Dimitrova D; Gynecology and Gynecologic Oncology, Charité University Medicine Campus Virchow, Augustenburger Platz 1, 13353, Berlin, Germany., Camara O; Centre for Gynecology, Hufeland Clinic, Bad Langensalza, Germany., Runnebaum IB; Clinic for Gynecology and Obstetrics, University Clinic, Jena, Germany., Tessen HW; Oncology Practise, Goslar, Germany., Rautenberg B; Gynecology and Gynecologic Oncology, University Clinic, Freiburg, Germany., Chekerov R; Gynecology and Gynecologic Oncology, Charité University Medicine Campus Virchow, Augustenburger Platz 1, 13353, Berlin, Germany., Muallem MZ; Gynecology and Gynecologic Oncology, Charité University Medicine Campus Virchow, Augustenburger Platz 1, 13353, Berlin, Germany., Lux MP; Department of OOGYN, Gyncecological University Cancer Center of Franconia, University Hospital Erlangen, CCC Erlangen-EMN, Erlangen, Germany., Trarbach T; iOMEDICO Clinical Research, Freiburg, Germany., Gitsch G; Gynecology and Gynecologic Oncology, University Clinic, Freiburg, Germany.

Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2017 Mar; Vol. 143 (3), pp. 541-550. Date of Electronic Publication: 2016 Nov 28.